Recent studies with tau and amyloid PET supports a view of AD as a tauopathy driven by amyloid, suggesting that tau pathology would appear in middle temporal lobe earlier than amyloid deposits, but the co-occurrence of both would be needed for tau pathology to expand beyond the temporal lobes (Schöll et al., 2016). This evidence concerns the gene MAPT and tauopathy.